BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 4589187)

  • 1. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
    J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone and triamterene in volume-dependent essential hypertension.
    DeCarvalho JG; Emery AC; Frohlich ED
    Clin Pharmacol Ther; 1980 Jan; 27(1):53-6. PubMed ID: 6985854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-renin hypertension. Restoration of normotension and renin responsiveness.
    Spark RF; O'Hare CM; Regan RM
    Arch Intern Med; 1974 Feb; 133(2):205-11. PubMed ID: 4591266
    [No Abstract]   [Full Text] [Related]  

  • 5. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS; Johnson CA; Kotchen JM; Kotchen TA
    Clin Pharmacol Ther; 1977 Jul; 22(1):14-20. PubMed ID: 326459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrochlorothiazide and spironolactone in hypertension.
    Schrijver G; Weinberger MH
    Clin Pharmacol Ther; 1979 Jan; 25(1):33-42. PubMed ID: 363334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
    Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E
    Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintenance of potassium balance during diuretic therapy.
    Kohvakka A; Eisalo A; Manninen V
    Acta Med Scand; 1979; 205(4):319-24. PubMed ID: 373393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of hydrochlorothiazide plus triameterene therapy versus chlorthalidone therapy in hypertension.
    Clark EC; Podolsky S; Thompson EJ
    South Med J; 1979 Jul; 72(7):798-802. PubMed ID: 377507
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal physiology and the treatment of hypertension.
    Cade R; Juncos L; Tarrant D; Mahoney J; Raulerson D
    Compr Ther; 1977 Jan; 3(1):41-7. PubMed ID: 318955
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of triamterene on plasma and extracellular fluid volume and blood pressure in ten thiazide-treated hypokalemic patients with essential hypertension.
    Leth A; Ibsen H; Sederberg-Olsen P
    Scand J Clin Lab Invest; 1972 Dec; 30(4):437-40. PubMed ID: 4639649
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertension with hydrochlorothiazide and spironolactone.
    Ogilvie RI; Ruedy J
    Can Med Assoc J; 1969 Nov; 101(10):61-4. PubMed ID: 5348877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 14. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension.
    Ferguson RK; Turek DM; Rovner DR
    Clin Pharmacol Ther; 1977 Jan; 21(1):62-9. PubMed ID: 318952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
    Acchiardo S; Dustan HP; Tarazi RC
    Cleve Clin Q; 1972; 39(4):153-62. PubMed ID: 4660197
    [No Abstract]   [Full Text] [Related]  

  • 17. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L
    Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.
    Hollifield JW
    South Med J; 1976 Aug; 69(8):1034-6. PubMed ID: 785608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.